{"AllianceGenome": "18696", "HGNC": "18696", "MIM": "606815", "_id": "163732", "_version": 1, "accession": {"genomic": ["AC119677.2", "AF362074.1", "AF466291.1", "CH471059.2", "CP068277.2", "CS589327.1", "CS589365.1", "CS684677.1", "CS684715.1", "NC_000001.11", "NC_060925.1"], "protein": ["AAH35496.1", "AAH52559.1", "AAK64235.1", "AAL73989.1", "CAN89457.1", "CAN89458.1", "CAP11404.1", "CAP11405.1", "EAX07195.1", "NP_597724.1", "Q96RK1.1"], "rna": ["BC035496.2", "BC052559.1", "NM_133467.3"], "translation": [{"protein": "AAH52559.1", "rna": "BC052559.1"}, {"protein": "AAH35496.1", "rna": "BC035496.2"}, {"protein": "NP_597724.1", "rna": "NM_133467.3"}]}, "ensembl": {"gene": "ENSG00000179862", "protein": "ENSP00000361721", "transcript": "ENST00000372638", "translation": [{"protein": "ENSP00000361721", "rna": "ENST00000372638"}], "type_of_gene": "protein_coding"}, "entrezgene": "163732", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 0.474546051000695, "exp_mis": 35.0452663836188, "exp_syn": 25.9499221734279, "lof_z": 0.682384025312422, "mis_z": 1.49095709695748, "mu_lof": 1.30605907445e-07, "mu_mis": 1.23399277082e-05, "mu_syn": 9.12772988016e-06, "n_lof": 0.0, "n_mis": 17.0, "n_syn": 10.0, "p_li": 0.358265028581015, "p_null": 0.158932088776727, "p_rec": 0.482802882642258, "syn_z": 1.94106442169493}, "bp": 555, "cds_end": 41327799, "cds_start": 41327244, "n_exons": 1, "nonpsych": {"exp_lof": 0.424352983412995, "exp_mis": 31.7141918643107, "exp_syn": 23.4820227776626, "lof_z": 0.639757830097766, "mis_z": 1.58655876967931, "mu_lof": 1.30605907445e-07, "mu_mis": 1.23399277082e-05, "mu_syn": 9.12772988016e-06, "n_lof": 0.0, "n_mis": 14.0, "n_syn": 10.0, "p_li": 0.383755562562962, "p_null": 0.156153931407567, "p_rec": 0.46009050602947, "syn_z": 1.75166368198076}, "nontcga": {"exp_lof": 0.436079712613241, "exp_mis": 32.2411448315267, "exp_syn": 23.8734228021382, "lof_z": 0.651424644335482, "mis_z": 1.51276227696087, "mu_lof": 1.30605907445e-07, "mu_mis": 1.23399277082e-05, "mu_syn": 9.12772988016e-06, "n_lof": 0.0, "n_mis": 15.0, "n_syn": 9.0, "p_li": 0.366606078709838, "p_null": 0.152208373851716, "p_rec": 0.481185547438446, "syn_z": 1.92741763512915}, "transcript": "ENST00000372638.2"}, "exons": [{"cdsend": 40862127, "cdsstart": 40861572, "chr": "1", "position": [[40861053, 40862363]], "strand": -1, "transcript": "NM_133467", "txend": 40862363, "txstart": 40861053}], "exons_hg19": [{"cdsend": 41327799, "cdsstart": 41327244, "chr": "1", "position": [[41326725, 41328035]], "strand": -1, "transcript": "NM_133467", "txend": 41328035, "txstart": 41326725}], "generif": [{"pubmed": 11744733, "text": "CITED4 functions as a transactivator when artificially targeted to a promoter element. CITED4 physically interacts with all TFAP2 isoforms in vitro and strongly co-activates all TFAP2 isoforms in Hep3B cells."}, {"pubmed": 15342390, "text": "Results show that breast cancer development is characterized by either nuclear loss or cytoplasmic translocation of CITED4, with consequent loss of hypoxia-inducible factor-1alpha transcriptional antagonist activity."}, {"pubmed": 15572674, "text": "The interaction and functional cooperation between FHL2, CITED4, and CTNNB were studied."}, {"pubmed": 17311001, "text": "CITED4 is epigenetically silenced in the vast majority of oligodendroglial tumours with 1p and 19q deletions."}, {"pubmed": 18722883, "text": "mutational study of CITED4 in 24 glial tumors (22 primary glioblastomas, 1 low-grade astrocytoma & its recurrent secondary glioblastoma)"}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21755341, "text": "Demethylation and histone modification can potentially reactivate CITED4 gene expression in some breast cancers and lead to changes in tumour behaviour."}, {"pubmed": 26243458, "text": "Upregulation of CITED4 is associated with colorectal cancer."}, {"pubmed": 29098625, "text": "Studies indicate that CCAAT enhancer binding protein beta (C/EBPB)-transcription factor CITED4 (CITED4) signaling is a pathway in cardioprotection mediating benefits of exercise in heart."}, {"pubmed": 33759374, "text": "CITED4 enhances the metastatic potential of lung adenocarcinoma."}], "genomic_pos": {"chr": "1", "end": 40862363, "ensemblgene": "ENSG00000179862", "start": 40861054, "strand": -1}, "genomic_pos_hg19": {"chr": "1", "end": 41328018, "start": 41326729, "strand": -1}, "go": {"BP": [{"evidence": "ISS", "gocategory": "BP", "id": "GO:0043627", "qualifier": "involved_in", "term": "response to estrogen"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045893", "qualifier": "involved_in", "term": "positive regulation of DNA-templated transcription"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005737", "qualifier": "located_in", "term": "cytoplasm"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0003713", "qualifier": "enables", "term": "transcription coactivator activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0003713", "qualifier": "enables", "term": "transcription coactivator activity"}]}, "homologene": {"genes": [[9598, 746795], [9606, 163732], [9913, 504742], [10090, 56222], [10116, 114491]], "id": 10474}, "interpro": {"desc": "CITED", "id": "IPR007576", "short_desc": "CITED"}, "ipi": "IPI00045365", "map_location": "1p34.2|1p35-p34", "name": "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4", "other_names": ["MRG-2", "MSG1-related protein 2", "cbp/p300-interacting transactivator 4", "transcriptional co-activator 4"], "pantherdb": {"HGNC": "18696", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1861694", "ortholog_type": "LDO", "panther_family": "PTHR17045", "taxid": 10090, "uniprot_kb": "Q9WUL8"}, {"RGD": "620113", "ortholog_type": "LDO", "panther_family": "PTHR17045", "taxid": 10116, "uniprot_kb": "Q99MA0"}, {"Ensembl": "ENSGALG00000000678", "ortholog_type": "LDO", "panther_family": "PTHR17045", "taxid": 9031, "uniprot_kb": "Q9I8K7"}, {"ZFIN": "ZDB-GENE-030131-7661", "ortholog_type": "O", "panther_family": "PTHR17045", "taxid": 7955, "uniprot_kb": "Q1L8S4"}, {"ZFIN": "ZDB-GENE-030425-5", "ortholog_type": "LDO", "panther_family": "PTHR17045", "taxid": 7955, "uniprot_kb": "Q90ZR5"}], "uniprot_kb": "Q96RK1"}, "pathway": {"reactome": [{"id": "R-HSA-212436", "name": "Generic Transcription Pathway"}, {"id": "R-HSA-73857", "name": "RNA Polymerase II Transcription"}, {"id": "R-HSA-74160", "name": "Gene expression (Transcription)"}, {"id": "R-HSA-8864260", "name": "Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors"}, {"id": "R-HSA-8866907", "name": "Activation of the TFAP2 (AP-2) family of transcription factors"}]}, "pfam": "PF04487", "pharmgkb": "PA38643", "pharos": {"target_id": 539, "tdl": "Tbio"}, "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF174940", "relationship": "is"}, {"id": "GNF185846", "relationship": "is"}, {"id": "GNF196752", "relationship": "is"}, {"id": "GNF207658", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF002631", "relationship": "is"}, {"id": "GNF002632", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF100281", "relationship": "is"}, {"id": "GNF139936", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000001.11", "NC_060925.1"], "protein": "NP_597724.1", "rna": "NM_133467.3", "translation": {"protein": "NP_597724.1", "rna": "NM_133467.3"}}, "reporter": {"GNF1H": ["gnf1h09371_at", "gnf1h09372_x_at"], "HG-U133_Plus_2": "228625_at", "HTA-2_0": "TC01002561.hg.1", "HuEx-1_0": "2408437", "HuGene-1_1": "7915347", "HuGene-2_1": "16685868"}, "summary": "The protein encoded by this intronless gene belongs to the CITED family of transcriptional coactivators that bind to several proteins, including CREB-binding protein (CBP) and p300, via a conserved 32 aa C-terminal motif, and regulate gene transcription. This protein also interacts with transcription factor AP2 (TFAP2), and thus may function as a co-activator for TFAP2. Hypermethylation and transcriptional downregulation of this gene has been observed in oligodendroglial tumors with deletions of chromosomal arms 1p and 19q, and associated with longer recurrence-free and overall survival of patients with oligodendroglial tumors. [provided by RefSeq, Aug 2011].", "symbol": "CITED4", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1425716"}, "unigene": "Hs.355820", "uniprot": {"Swiss-Prot": "Q96RK1"}}